Eletriptan

Back to search

Molecule Structure

Scientific Name

Eletriptan

Description of the Drug

Eletriptan is a triptan used for the treatment of migraines.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00216

Brand Name(s)

Relpax

Company Owner(s)

Amneal Pharmaceuticals Co Gmbh, Teva Pharmaceuticals Usa Inc, Ajanta Pharma Ltd, Upjohn Manufacturing Ireland Unltd, Yung Shin Pharmaceutical Industrial Co Ltd, Aurobindo Pharma Ltd, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Beximco Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Serotonin 1f (5-HT1f) receptor SINGLE PROTEIN AGONIST CHEMBL1805
Serotonin 1d (5-HT1d) receptor SINGLE PROTEIN AGONIST CHEMBL1983
Serotonin 1b (5-HT1b) receptor SINGLE PROTEIN AGONIST CHEMBL1898

Unichem Links

SureChEMBL SCHEMBL26719
PharmGKB PA134687947
Human Metabolome Database HMDB0014361
DrugBank DB00216
PubChem: Thomson Pharma 14927226 14829466
PubChem 77993
Nikkaji J979.643F
BindingDB 50103594
EPA CompTox Dashboard DTXSID9046861
DrugCentral 995
ChemicalBook CB1404591
Guide to Pharmacology 40
rxnorm ELETRIPTAN ELETRIPTAN HYDROBROMIDE RELPAX
PubChem: Drugs of the Future 12014973
ChEBI 50922
ZINC ZINC000003823475